You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2-positive breast cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

Breast Diseases Trial in Istanbul (Analgesia management; group S and C)

Not yet recruiting
  • Breast Diseases
  • Analgesia management; group S and C
  • Istanbul, Bagcilar, Turkey
    Istanbul Medipol University Hospital
Jul 25, 2023

Hepatocellular Carcinoma Trial in Seoul (RZ-001 Dose 1, RZ-001 Dose 2, RZ-001 Dose 3)

Recruiting
  • Hepatocellular Carcinoma
  • RZ-001 Dose 1
  • +3 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Oct 25, 2022

MDD Trial in Pittsburgh (real-time fMRI neurofeedback: Amygdala, real-time fMRI neurofeedback: HIPS)

Completed
  • Major Depressive Disorder
  • real-time fMRI neurofeedback: Amygdala
  • real-time fMRI neurofeedback: HIPS
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Dec 2, 2022

Breast Cancer Trial in Caen (Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.)

Completed
  • Breast Cancer
  • Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.
  • Caen, France
    centre François Baclesse
Mar 7, 2022

Metastatic Neuroblastoma Trial in London, Sutton ([124I]meta-Iodobenzylguanidine)

Completed
Has Results
  • Metastatic Neuroblastoma
  • London, United Kingdom
  • +1 more
May 27, 2021

Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)

Not yet recruiting
  • Tuberculosis
  • M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
  • Placebo
  • Bandung, Indonesia
  • +59 more
Sep 25, 2023

Breast Cancer, Quality of Life, Physical Activity Trial in La Jolla (Exercise Intervention)

Completed
  • Breast Cancer
  • +2 more
  • Exercise Intervention
  • La Jolla, California
    University of California, San Diego
Nov 2, 2020

Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Induction Chemotherapy Triplet Therapy
  • +2 more
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jun 14, 2022

COVID-19 and Mental Health in Eure

Recruiting
  • COVID-19 Pandemic
  • Psychiatric Disorder
  • Questionnaires
  • Évreux, France
    CH Eure-Seine
Nov 7, 2022

Mood, Healthy, Mothers Trial in Reading (Flavonoid-rich diet)

Completed
  • Mood
  • +4 more
  • Flavonoid-rich diet
  • Reading, Berkshire, United Kingdom
    University of Reading
May 9, 2022

PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

Not yet recruiting
  • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
  • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
  • (no location specified)
Sep 24, 2023

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Heterogeneity of Dendritic Cells in Colon and Non-small Cell

Recruiting
  • Non-small Cell Lung Cancer
  • Bioinformatics analysis of single cell transcriptomics data
  • Monza, Italy
  • +1 more
Jul 21, 2022

Breast Cancer Trial in Houston (Dasatinib, AZD6244)

Terminated
Has Results
  • Breast Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

Completed
Has Results
  • Neuroendocrine Tumors
  • +3 more
  • 68Ga-DOTATOC PET/CT
  • Iowa City, Iowa
    University of Iowa Health Care
Jul 24, 2021

Obesity, Morbid Trial (Reimagining Us in the Context of Bariatric Surgery (ReConnect))

Not yet recruiting
  • Obesity, Morbid
  • Reimagining Us in the Context of Bariatric Surgery (ReConnect)
  • (no location specified)
Jul 21, 2023

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Breast Cancer Trial in Sutton (radiation therapy)

Unknown status
  • Breast Cancer
  • radiation therapy
  • Sutton, England, United Kingdom
    Royal Marsden - Surrey
Feb 26, 2019

Energy Trial in Canfield (Dynamine (methylliberine))

Completed
  • Energy
  • Dynamine (methylliberine)
  • Canfield, Ohio
    The Center for Applied Health Sciences
Sep 20, 2023

Cancer Trial in Qina, (Cryotherapy (apparatus))

Recruiting
  • Cancer
  • Cryotherapy (apparatus)
  • Qina,, Egypt
    South Valley University, Faculty of Physical Therapy
Oct 13, 2021

Bladder Cancer Trial in United States (Mitomycin C, Chemophase)

Completed
Has Results
  • Bladder Cancer
  • Phoenix, Arizona
  • +4 more
Sep 30, 2021

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Uterine Cervical Tumors, Uterine Cervical Cancer, Tumors, Squamous Cell Trial in Seattle (BD SurePath Plus Pap test, BD SurePath

Terminated
Has Results
  • Uterine Cervical Neoplasms
  • +6 more
  • BD SurePath Plus Pap test
  • +3 more
  • Seattle, Washington
    Seattle Women's: Health, Research, Gynecology
Apr 12, 2021

Bladder Cancer Patients to Detect Recurrences After TURB Earlier

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Xpert Bladder Cancer Monitor
  • Salzburg, Austria
  • +12 more
Aug 3, 2021